CAS: 1853279-29-4 - B-[(7α,17β)-17-Hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]boronic acid

Formel: C₃₂H₄₈BF₅O₄S

InChl: InChI=1S/C32H48BF5O4S/c1-30-17-15-26-25-12-11-24(33(40)41)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-43(42)19-9-16-31(34,35)32(36,37)38/h11-12,21-22,26-29,39-41H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,43?/m1/s1

InChI Key: InChIKey=FIAYIYKWRBIBQG-GDWZZRAASA-N

SMILES: O=S(CCCCCCCCCC1CC2=CC(=CC=C2C3CCC4(C)C(O)CCC4C31)B(O)O)CCCC(F)(F)C(F)(F)F

Synonyme:

• Boronic acid, B-[(7α,17β)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-
• ZB716
• ZB 716
• Fulvestrant-3-boronic Acid
• B-[(7α,17β)-17-Hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]boronic acid

ZB716

CAS: 1853279-29-4

ZB716 is a novel, orally bioavailable compound that inhibits the activity of CDK4/6 and shows …

• Formel: C₃₂H₄₈BF₅O₄S
• Reinheit: Min. 95%
• Molekulargewicht: 634.6 g/mol